Oriola Oyj
OKDAV
Rangering i aksjer
#17850
Operating in Sweden, Finland, and internationally, Oriola Oyj is a key provider... Operating in Sweden, Finland, and internationally, Oriola Oyj is a key provider of healthcare and wellbeing products. Their diverse product portfolio includes over-the-counter (OTC) pharmaceuticals, general merchandise, vitamins, dietary supplements, cosmetics, skincare products, sports drinks, and wound care items. Beyond products, Oriola offers essential services such as logistics, advisory support, and comprehensive sales and marketing solutions for pharmaceutical companies, retail and hospital pharmacies, veterinary practices, and grocery retailers. The company also specializes in pharmaceutical staffing and dose dispensing services, catering to both public and private healthcare operators, pharmacies, groceries, veterinarians, and various other retailers. As of December 31, 2021, Oriola managed 319 physical pharmacies in Sweden and maintained a strong online pharmacy presence. Oriola Oyj, which was previously known as Oriola-KD Oyj until its name change in April 2017, is headquartered in Espoo, Finland.
Aksjekurs
$1.16
Sist synkronisert: 2025-04-30
Markedsverdi
$209.58M
Endring (1 dag)
-0.57%
Endring (1 år)
0.00%
Land
FI
Handel Oriola Oyj (OKDAV)
Kategori
Healthcare
Inntekter for Oriola Oyj (OKDAV)
Inntekter i Oct 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Oriola Oyj er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Oriola Oyj fra 2026 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $410.98B | - |
US
|
|
| - | - |
US
|
|
| $254.25B | - |
US
|
|
| - | - |
US
|
|
| $7.64B | - |
AU
|
